TRILLIUM THERAPEUTICS INC. Marketable Securities (Current)
TRILLIUM THERAPEUTICS INC. had Marketable Securities (Current) of $157.45 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-11-12
- 2021-09-30: Marketable Securities, Current $157.45M.
- 2021-06-30: Marketable Securities, Current $94.70M.
- 2020-12-31: Marketable Securities, Current $43.56M.
| Period end | Marketable Securities, Current |
|---|---|
| 2021-09-30 | $157.45M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $94.70M 10-Q · filed 2021-08-13 |
| 2020-12-31 | $43.56M 10-Q · filed 2021-11-12 |